Introduction
Adipose tissue has two principal functions, the storage of excess nutrients as triglycerides and the hydrolysis of triglycerides to release free fatty acids (FFAs) and glycerol into the plasma. Given that there is only a small reservoir of FFAs ( 0.1 g/L) plus esterified fatty acids (FAs; 1.5 g/L) in the bloodstream, adipocyte lipolysis is the most important process controlling FA supply to all tissues. Lipolysis in adipocytes is maintained at a low basal level in quiescent conditions and is physiologically stimulated by catecholamine hormones. The lipolysis process is catalysed by two major enzymes, hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL), both of which are regulated by perilipin-1 (Plin1). 1 Perilipin-1 is the first identified member of the perilipin family of five lipid-droplet proteins (perilipins-1 to -5), loosely grouped according to the similarity of their first 100 amino-terminal residues.
1 Unlike perilipins-2 to -5, which coat intracellular lipid droplets and are distributed in other cytoplasmic compartments in various types of cells, Plin1 localizes only at the surface of lipid droplets, exclusively in adipocytes and steroidogenic cells. Consistent with this model, down-regulation of Plin1 may dilute its protective barrier, leading to increased lipolysis despite the absence of a typical adrenergic stimulus for lipolysis. 6 -8 Defective Plin1 levels primarily cause adipose tissue dysfunction and metabolic disturbances. Plin1-deficient (Plin1 2/2 ) mice have low body fat, high metabolic rate, high basal lipolysis close to the maximal lipolytic response to adrenergic stimulation, hypertriglyceridaemia, and insulin resistance. 9 -11 Plin1 mutations in humans cause partial lipodystrophy syndrome associated with hypertriglyceridaemia, insulin-resistant diabetes, and ectopic lipid accumulation in the liver. 12 The heart has a high energy demand, of which 70% is provided by FA b-oxidation. When the energy substrate supply is altered, the heart can adapt to ensure its pump function. For example, in obesity and diabetes, which are associated with increased plasma FFA content and insulin resistance, the heart shifts its energy expenditure almost exclusively to FA oxidation. 13 -15 Unfortunately, the persistently altered supply and utilization of FAs has deleterious consequences for cardiac lipid metabolism and contributes to the development of metabolic cardiomyopathy in obese and diabetic conditions.
-15
Here, we investigated a novel phenotype of hypertrophic cardiomyopathy with adipose tissue dysfunction in Plin1 2/2 mice. We demonstrate that adipose-tissue dysfunction in Plin1 2/2 mice is linked to increased FA transport and utilization, lipotoxicity, oxidative stress, and severe mitochondrial and myofilament abnormalities in cardiomyocytes, and, finally leads to cardiac hypertrophy and failure. Our findings highlight that adipose tissue dysfunction has deleterious consequences for the heart and contributes to the development of metabolic cardiomyopathy.
Methods

Materials
Polyclonal antibodies against Plin1 or Plin2 16 were gifts from the laboratory of C. Londos (US National Institutes of Health). Other antibodies were from Abcam and Santa Cruz Biotechnology. Enzyme materials for enzymatic assays were from Totobo Co. (Tokyo).
Animals and plasma chemistry
The animal study was performed in accordance with the NIH guidelines for the care and use of laboratory animals and approved by the animal care and utilization committee of Peking University. Plin1 2/2 mice in a pure 129/SvEv background were a gift from the laboratory of C. Londos (US National Institutes of Health). 9, 11 Mice were housed and bred in a pathogen-free barrier facility. Plin1 2/2 and 129/SvEv mice were crossed to generate Plin +/2 mice; these heterozygotes were intercrossed to obtain Plin1 2/2 mice and their control wild-type littermates. Mice were killed by cervical dislocation after receiving pentobarbital (40 mg/kg, i.p.). For plasma chemistry, male mice were fed ad libitum or fasted for 4 h. Plasma concentrations of glucose, glycerol, triglycerides, and cholesterols were determined by use of the enzyme-coupled assay kits (Applygen Technologies, Beijing). Plasma FFA levels were measured by the cupric acetate-pyridine method. 6 Plasma insulin was measured by 125 I radioimmunoassay. 23-week old mice were fasted for 6 h for the insulin tolerance test (ITT) or for 16 h for the glucose tolerance test (IGTT), with an i.p. injection of insulin or glucose, respectively. Glucose was measured with the Roche glucometer.
Lipolysis assay
Minced fat fragments were incubated for 1 h at 378C in 0.3 mL phenol red-free and serum-free Dulbecco's modified Eagle's medium supplied with 1% defatted albumin. Glycerol release into the medium was determined by an enzyme-coupled assay with absorption at 550 nm, as an index of lipolysis. 8 
Immunoblotting and real-time PCR
Equal amounts of protein were separated on SDS-PAGE and underwent immunoblotting analysis with primary antibodies and horseradish peroxidase-conjugated IgG. The blots were developed with enhanced chemiluminescence detection reagents (Applygen Technologies, Beijing). The methods for RT-PCR and mitochondrial DNA analysis are described in the Supplementary material online.
Cardiac histology and four-chamber view
Mouse hearts were removed and arrested in diastole in cold phosphatebuffered saline containing 14 mmol/L KCl. Hearts were fixed and embedded, after which they were cut along the coronal plane to visualize the fourchamber view, or sectioned transversely close to the apex to visualize left (LV) and right ventricles. Sections were stained with haematoxylin and eosin for routine histology. For electron microscopy, LV tissues were fixed with 3% glutaraldehyde and post-fixed with 1% osmium tetroxide. Ultrathin (70 nm) sections were cut, stained with uranyl acetate and lead citrate, and examined under a JEM-1230 ExII electron microscope.
Fluorescence
To measure cardiomyocyte size, frozen LV sections were stained with fluorescein isothiocyanate-conjugated wheat-germ agglutinin (Invitrogen). Myocyte cross-sectional area was measured using image-processing software linked to the fluorescence microscope. After frozen left-ventricular sections had been stained with 0.3% oil-red O in 36% triethylphosphate, intracellular lipid droplets were examined under bright-field microscopy and fluorescence microscopy with a Texas red excitation filter (540-580 nm) for red fluorescence signals. To detect fluorescence of reactive oxygen species (ROS), frozen LV sections were incubated with 5 mM dihydroethidium and observed at 610 nm with excitation at 488 nm. Mitochondrial ROS production in frozen cardiac tissue sections was probed with MitoTracker Red CM-H2XRos dye (Invitrogen) and examined with a 590 nm filter.
Cardiac function
Two-dimensional guided M-mode echocardiography was used for the noninvasive assessment of heart function in mice (VisualSonics Vevo 770). End systole or end diastole was defined as the phase with the smallest or largest left ventricular area, respectively. All measurements were performed over four cardiac cycles. In parallel, mice anaesthetized with pentobarbital (40 mg/kg, i.p.) and local lidocaine infiltration underwent cardiac catheterization for invasive measurement of absolute LV pressure. We prepared the catheters from polyethylene tubing, 8 cm in length, by increasing the inner tube diameter from 0.5 mm at the narrow end to 4 mm at the widest end. The narrow end was inserted into right carotid artery and advanced into the left ventricle. The wide end was coupled to a Powerlab/4SP A/D converter for recordings of LV pressure and its derivatives. The maximal rates of LV pressure increase and decrease (LV +dP/dt max ) were calculated automatically.
Myocardial triglyceride and FA contents
Myocardial FA content was determined by a colorimetric assay as previously described. 6 To measure the myocardial triglyceride content, heart tissue was homogenized in the extraction solution and heated to 708C for 10 min to inactivate endogenous lipase. After centrifugation at 10 000 g for 5 min, triglyceride content in the supernatant was determined by an enzyme-coupled commercial assay (Applygen Technologies, Beijing).
Cardiomyopathy and adipose tissue dysfunction
Mitochondrial enzyme activities and FA oxidation
The mitochondrial fraction was isolated from heart homogenates. Mitochondrial carnitine palmitoyltransferase 1 (CPT1) activity was assayed by measuring carnitine-dependent CoA conversion from palmitoyl-CoA spectrophotometrically. Fatty acid synthase (FAS) activity in the crude mitochondrial fraction was determined spectrophotometrically from the rate of malonyl-CoA-dependent NADPH oxidation. Palmitate b-oxidation was measured by monitoring 3 H 2 O production from the metabolism of [9, H(N)]-palmitic acid (New England Nuclear) in the fresh homogenate of cardiac tissue as described. 17 The substrates used were 3 H-palmitic acid (1 mCi) and palmitic acid (200 mmol/L) bound to defatted albumin. After 40 min of incubation at 378C, the mixture was extracted with chloroform and methanol (2:1 v/v) and centrifuged at 3 000 g for 5 min; 3 H 2 O production was partitioned to the aqueous phase and next determined by a scintillation counter.
Evaluation of oxidative stress
Malondialdehyde as a part of thiobarbituric acid reacting substances was assayed and used as an indicator of lipid peroxidation. The total content of glutathione and its oxidized form, glutathione disulfide (GSSG), was assayed spectrophotometrically using sulfhydryl reagent. The amount of the reduced sulfhydryl form (GSH) and ratio of GSH/GSSG was calculated. A low GSH/GSSG ratio indicates increased cellular oxidative stress.
Statistics
Data are shown as mean values + SEM. Student's unpaired t-test and one-or two-way ANOVA were used for statistical analysis with use of GraphPad Prism 4.0. A value of P , 0.05 was considered statistically significant.
Results
Adipose tissue dysfunction and metabolic disturbances in Plin1
2/2 mice
Compared with wild-type littermates, Plin1 2/2 mice showed a significantly low capacity for adipose triglyceride storage, with a reduced mass of inguinal, epididymal, retroperitoneal, and brown fat ( Figure 1A ). Basal lipolysis and glycerol release ex vivo from inguinal and epididymal adipose tissues were significantly higher for Plin1 2/2 than wild-type mice; however, the maximal lipolysis with isoproterenol stimulation in inguinal tissue was attenuated near the basal lipolytic level in Plin1 2/2 mice, in comparison to a robust lipolytic response in wild-type mice ( Figure 1B ). Plasma glycerol levels were increased in fed and fasted Plin1 2/2 mice; however, plasma FFA levels were not elevated with ad libitum feeding and were decreased with 4 h of fasting in Plin1 2/2 mice ( Table 1) . This discrepancy may reflect increased FFA utilization in various tissues because of the systemically increased metabolic rate in Plin1 2/2 mice. 9,10 Plasma FFAs are derived from multiple sources and used quickly by various tissues, but circulating glycerol originates mainly from adipocyte lipolysis, proportionally along with FFAs, and its turnover is slow, so increased glycerol can provide an accurate indication of increased lipolysis and FFA efflux to plasma in vivo in Plin1 2/2 mice. Plasma levels of glucose, insulin, and triglycerides, but not cholesterol, were elevated in Plin1 2/2 mice ( Table 1) . The intraperitoneal glucose tolerance test ( Figure 1C ) and insulin tolerance test ( Figure 1D ) revealed increased insulin resistance (Supplementary material online, Figures S1 and S2) in 23-week-old Plin1 2/2 mice.
Cardiac hypertrophy and dysfunction
Plin1
2/2 and control mice had a similar lifespan and body weight. For male Plin1 2/2 mice, heart weight and the ratio of heart to body weight were normal at 5 weeks but progressively increased at 10 and 20 weeks of age ( Table 2 ). The phenotype of cardiac hypertrophy was visible in Plin1
mice at 20 weeks of age ( Figure 1E , top), and four-chamber views demonstrated typical morphological features of left ventricular hypertrophy ( Figure 1E , bottom). Plin1 2/2 mice at 20 weeks of age had enlarged cardiomyocytes ( Figure 1F ) and an increase in the mean cross-sectional area of cardiomyocytes ( Figure 1G ). Cardiac mRNA levels of atrial-and brain-type natriuretic peptide ( Figure 1H and I) and b-myosin heavy chain ( Figure 1J) , markers of cardiac hypertrophy and cardiac dysfunction, were up-regulated at 10 and 20 weeks of age. Cardiac function was near normal in 10-week-old Plin1 2/2 mice ( Figure 2A , Table 3 ). At 20 weeks of age, however, ejection fraction and fractional shortening were significantly decreased, which suggests an impaired pump function in Plin1 2/2 mice ( Figure 2A and Table 3 ). The LV internal diameter, LV anterior wall thickness, and LV posterior wall thickness in end systole and end diastole were significantly increased, which suggests cardiac hypertrophy. In addition, we used the custom-made fluid-filled catheter to measure LV pressure ( Figure 2B ). Left ventricular contractility parameters did not differ between Plin1 2/2 and wild-type mice at 5 weeks of age ( Figure 2B -F).
At 20 weeks of age, the LV end-systolic pressure (LVESP; Figure 2C ) was unchanged, but LV end-diastolic pressure ( Figure 2D ) was increased 3-fold in Plin1 2/2 mice, and LV +dP/dt max was markedly decreased ( Figure 2E and F). Thus, Plin1 2/2 mice showed a transition from hypertrophy to heart failure at 20 weeks of age, with dysfunction of LV contractility and relaxation.
Cardiac lipid accumulation
The protein level of Plin2 was increased in Plin1 2/2 adipose tissues ( Figure 3A ; Supplementary material online, Figure S3 ) because of its substitution for Plin1 on the lipid-droplet surface in Plin1 2/2 adipocytes. 4 In contrast, Plin1 protein was undetectable in the heart of Pin1 +/+ or Pin1 2/2 mice, and Plin1 ablation was not coupled with an increase in the level of Plin2 ( Figure 3B ). Also, cardiac Plin5 expression did not differ between Plin1 2/2 and wild-type mice ( Figure 3B ). Hormone-sensitive lipase is located predominately in adipocytes, so it was undetectable in the heart (data not shown). Adipose triglyceride lipase exists in various tissues. 18 The expression of myocardial ATGL and FAS was unaltered in Plin1 2/2 mice ( Figure 3B ; Supplementary material online, Figure S4 ), as was the activity of cardiac lipases and FAS enzymes ( Figure 3C and D) . The protein levels of diacylglycerol acyltransferase-1 (DGAT1) and DGAT2 were moderately increased ( Figure 3B ). Diacylglycerol acyltransferase-mediated triglyceride synthesis but not endogenous triglyceride hydrolysis and FA synthesis de novo might account for cardiac lipid accumulation in Plin1 2/2 mice. The LV content of FAs ( Figure 3E ) and triglycerides ( Figure 3F ) was higher in Plin1 2/2 than in wild-type mice after they had fasted for 4 h. In the fed state, cardiomyocytes contained only tiny lipid droplets, but on fasting for .16 h, lipid droplets can be augmented because of increased delivery of FA from fat tissue. 19 Therefore, we examined cardiac lipid accumulation in mice fasted for 24 h . Bright-field microscopy ( Figure 3G , top) and fluorescence microscopy ( Figure 3G , bottom) showed that lipid droplets in cardiomyocytes of Plin1 2/2 mice were increased both in number and size (Supplementary material online, Figure S5 ). Electron microscopy revealed abundant lipid droplets near mitochondria in hearts of Plin1 2/2 mice fasted for 24 h ( Figure 3H ).
Increased transport and oxidation of myocardial fatty acids
Peroxisome proliferator-activated receptor a (PPARa) participates in the regulation of cardiac FA metabolism. The protein expression of PPARa and several PPARa targets was elevated in Plin1 2/ 2 mouse hearts ( Figure 4C ). The protein levels of FATP1 and CD36 were up-regulated in the hearts of Plin1 2/ 2 mice at 10, 20 and 30 weeks of age ( Figure 4A and B) . In the hearts of 20-week-old Plin1 mice, the levels of middle-chain acyl-CoA dehydrogenase (MCAD), long-CAD (LCAD), and very long-CAD (VLCAD) were up-regulated at translational ( Figure 4C and D) and transcriptional levels ( Figure 4E ).
The level of native acetyl-CoA carboxylase-2 (ACC2), a major isoform in cardiac and skeletal muscles, was not changed, but its phosphorylation was increased ( Figure 4C and D) . Phosphorylation of ACC2 triggers CPT1 activation to accelerate FA oxidation. 20 Immunoblotting analysis revealed increased CPT1 expression ( Figure 4C and D) , and CPT1 activity was increased in myocardial mitochondria ( Figure 4F ). Consistent with these changes, the rate of palmitate oxidation in heart homogenates was increased by 85% in Plin1 2/ 2 mice ( Figure 4G ). 
Oxidative stress and myocardial injury
Dihydroethidium is a reagent that reacts with a superoxide anion to form the DNA-binding fluorophore, ethidium bromide. In Plin1 2/2 mouse hearts, staining with dihydroethidium revealed strong fluorescence for superoxides in cardiomyocytes ( Figure 5A , top panel, and B). MitoTracker Red staining revealed strong ROS fluorescence in myocardial mitochondria ( Figure 5A , bottom panel, and C). A high level of cardiac malondialdehyde production indicated excess lipid peroxidation ( Figure 5D ). Catalase activity was decreased by 58% ( Figure 5E ), but superoxide dismutase activity was unchanged ( Figure 5F ). The antioxidant glutathione (GSH) neutralizes ROS via a detoxification cascade, while GSH is converted to an oxidized form, glutathione disulfide (GSSG). Spectrophotometry revealed a significant decrease in GSH/GSSG ratio ( Figure 5G ), which indicates a high level of oxidative stress but a low antioxidative capacity. Thus, Plin1 2/2 mice showed substantial oxidative stress, probably because of the low antioxidative capacity in cardiomyocytes. Hearts of Plin1 2/2 mice at 20 weeks of age showed a damaged myocardial structure, as evidenced by disorganized myofilaments and irregular and swollen mitochondria with disrupted cristae ( Figure 5H ). The number of cardiac mitochondria was unchanged at 10 weeks but decreased in 20 weeks old mice ( Figure 5I ), concomitant with a reduced mitochondrial DNA content ( Figure 5J ).
Discussion
The phenotype of cardiac hypertrophy in Plin1 2/2 mice was neglected in two earlier studies, probably because the animals studied were younger than 10 weeks or because of different genetic backgrounds. 9, 10 The 129/ SvEv Plin1 2/2 mice we used originated from a laboratory where one of the studies was carried out. 9 In addition, we generated Plin1 2/2 mice on a pure C57BL/6 background by transferring the Plin1 mutation loci, which also showed cardiac hypertrophy (data not shown), so the hypertrophic phenotype is independent of genetic background. The cardiac hypertrophy in 129/SvEv Plin1 2/2 mice appeared at 10 weeks of age, was grossly visible at 20 weeks, and was characterized by progressively enlarged cardiomyocytes and up-regulated expression of marker genes for cardiac hypertrophy and dysfunction, including atrial natriuretic peptide, brain natriuretic peptide, and b-myosin heavy-chain genes. The Plin1 2/2 mice had normal cardiac function at 10 weeks of age but showed heart failure with LV systolic and, in particular, diastolic dysfunction at 20 weeks of age. Unlike adipocyte-specific Plin1, other perilipin family members, Plin2-Plin5, are expressed in various tissues, and their roles are unclear. 21 the increased content faithfully indicated the robust lipolysis and FFA efflux in vivo from Plin1 2/2 adipocytes. The Plin1 2/2 mice could use fatty acids quickly, because these animals have a high metabolic rate 9, 10 together with high levels of FA oxidation in the liver and skeletal muscle, 27, 28 as well as in cardiac muscle, as we observed. Therefore, although the plasma FFA level was not elevated, the high plasma glycerol concentration confirmed the persistently increased FFA supply to various organs, including the heart, in Plin1 2/2 mice.
Such Plin1 2/2 adipose tissue dysfunction may indicate the primary pathophysiological basis for derangements in myocardial lipid accumulation and lipid metabolism, which then lead to deleterious consequences for the heart and hypertrophic cardiomyopathy. Excessive lipid accumulation in the cytoplasm of non-adipose cells is toxic and may lead to dysfunction of myocytes, known as lipotoxicity. 29 The Plin 2/2 mice accumulated significant amounts of both FAs and triglycerides in their cardiomyocytes. The accumulated myocardial lipids were probably not derived from triglyceride hydrolysis or de novo FA synthesis in the cardiomyocytes, because Plin1 deficiency did not influence the activities of total lipase and FAS. Peroxisome proliferator-activated receptor a plays important roles in the regulation of cardiac lipid metabolism.
14 Cardiac-specific expres- Previous studies suggested that CD36 mediates 50% of FA transport and oxidation in murine hearts, 34 and myocardial FATP1 expression increases cardiac FA uptake and utilization and causes lipotoxic cardiomyopathy. 31 We found up-regulated cardiac CD36 and FATP1 levels, which may accelerate transport of excess FA across the sarcolemmal membrane into cardiomyocytes. Increased DGAT1/2 could promote triglyceride synthesis by integrating FAs transported in the heart. As a rate-limiting enzyme, CPT1 catalyses the conversion of long-chain fatty acyl-CoA to acylcarnitine, which is then shuttled into the mitochondria for oxidation. We observed increased phosphorylation of ACC2, a major cardiac isoform of ACC, whose phosphorylation can trigger a regulatory cascade to activate CPT1. 20 Indeed, both CPT1 activity and the downstream palmitate b-oxidation were greatly increased in the Plin1 2/2 mouse heart.
Furthermore, we showed that Plin1 2/2 mouse hearts had excessive ROS products and oxidative stress. The promotion of mitochondrial FA oxidation in Plin1 2/2 mouse hearts might generate excess superoxides, because FA oxidation is the major process that produces ROS in mammalian cells, including cardiomyocytes. 35, 36 In addition, the elevated level of lipid peroxidation production suggests another source of ROS from peroxisomal oxidation. Finally, ROS toxicity depends on The myocardial mitochondria of Plin1 2/2 mice were reduced in number and became disorganized (top, ×10 000 magnification), irregular, swollen, and with disrupted cristae (boxed area in the middle, ×20 000 magnification, and at the bottom, ×30 000 magnification). Asterisks indicate disarranged myofilaments and arrows indicate distorted Z-disc structure. (I) The number of mitochondria was counted on four to seven electron micrographs (×20 000 magnification) for each heart and for three mice for each group and normalized to unit micrograph area. (J) Quantitative PCR analysis of relative mitochondrial DNA (mtDNA) content in mouse hearts (n ¼ 6). *P , 0.05 and **P , 0.01. Abbreviation: M, mitochondrion.
the amount of ROS and antioxidant defense mechanisms. Given that catalase activity, and the antioxidant GSH and the GSH/GSSG ratio were decreased, the cardiomyocytes in Plin1 2/2 mice have an impaired antioxidant ability to detoxify excess ROS, thus experiencing considerable oxidative stress. Recently, oxidative stress and lipotoxicity have been considered as the major causative factors of myocardial lesions and mediators of the development of the metabolic cardiomyopathies that occur with high rates of cardiac FA oxidation in obese and diabetic conditions. 13 -15,29,37 The detailed mechanisms by which ROS mediate cardiac hypertrophy and heart dysfunction are not fully understood, but in general involve activation of redox-sensitive hypertrophic signalling pathways, such as extracellular signal-regulated kinase, mitogenactivated protein kinase, c-Jun N-terminal kinase, and protein kinase C and B/Akt. 35, 36 Also, excess ROS activate the mitochondrial death pathway, leading to impaired sarcoplasmic reticulum calcium handling and contractile responses. 35, 36 Excess ROS and lipotoxicity in Plin1 2/2 mouse hearts might activate the redox-sensitive hypertrophic signalling pathways. This may in turn induce myofilament disorganization and cause myocardial mitochondria to swell, with disruption of the cristae, and, finally lead to LV hypertrophy and failure. Further studies are needed to investigate the role of redox-sensitive hypertrophic signalling in the development of cardiac hypertrophy in Plin1 2/2 mice.
In conclusion, our findings highlight a novel pathophysiological pathway that links adipose tissue dysfunction to maladaptive lipid metabolism, lipotoxicity, and oxidative stress lesions in the Plin1 2/2 mouse heart. These changes are associated with development of cardiac hypertrophy and failure. Lipodystrophy and obesity are two typical diseases of adipose tissue dysfunction. Paradoxically, both disorders have identical metabolic disturbances, and often occur with hypertrophic cardiomyopathy. 15, 38, 39 One explanation is that both disorders share intrinsically similar pathophysiological aspects despite having opposite histological appearances. Lipodystrophic patients lack adipocytes in which to store excess nutrients as body fat; therefore, they accumulate lipids in nonadipose organs. 38, 39 In severe obesity, the adipocytes are already too expanded to store more lipids, which, in turn, accumulate ectopically in non-adipose tissues, such as the liver and heart. 39 adipose dysfunction is worse than that observed in lipodystrophy or obesity alone, but comparable to the combined adipose dysfunction of the two diseases. Indeed, these disorders have similar metabolic consequences, such as lipotoxicity, cardiomyopathy, dyslipidaemia, and insulin resistance. Thus, as shown schematically in Figure 6 , Plin1 2/2 adipose tissue dysfunction, abnormal cardiac FA metabolism, and hypertrophic cardiomyopathy could mimic the relevant complications occurring in typical diseases of adipose tissue dysfunction, lipodystrophy, and obesity.
Supplementary material
Supplementary Material is available at Cardiovascular Research online. phenotype, yet its adipocytes, like those in obese mammals, show robust basal lipolysis and fatty acid (FA) efflux to the plasma. Thus, Plin1 2/2 adipose tissue dysfunction is a combination of two typical adipose tissue disorders: lipodystrophy and obesity. Moreover, its pathological consequences, such as dyslipidaemia, insulin resistance, lipotoxicity, and cardiomyopathy, are similar to those occurring in lipodystrophy and obesity. In Plin1 2/2 mice, the combination of limited fat storage and persistently increased FA efflux from adipocytes contributes to excess FA uptake and lipotoxicity in the heart, which results in excess FA transport and utilization, followed by oxidative stress and mitochondrial damage in cardiomyocytes. These maladaptive metabolic consequences of adipose tissue dysfunction could be the primary cause for the hypertrophic cardiomyopathy in the Plin1 2/2 mouse and in lipodystrophic or obese individuals.
